"Combined Overexpression of Bcl-2 and SOCS3 Is Associated with Decreased Survival in a Cohort of Patients with De Novo Follicular Lymphoma." by Ravitharan Krishnadasan

Selected Works of Carlo B. Bifulco, M.D.

Article

Combined Overexpression of Bcl-2 and SOCS3 Is Associated with Decreased Survival in a Cohort of Patients with De Novo Follicular Lymphoma.

Blood (2005)

Ravitharan Krishnadasan, Yale University
Carlo Bifulco, Yale University
Sofya Rodov, Yale University
Julie Kim, Yale University
K. Gary J. Vanasse, Yale University

Link

Disciplines

Medicine and Health Sciences,
Oncology,
Pathology,
Survival Analysis and
Internal Medicine

Publication Date

November 16, 2005

DOI

10.1182/BLOOD.V106.11.989.989

Citation Information

Ravitharan Krishnadasan, Carlo Bifulco, Sofya Rodov, Julie Kim, et al.. "Combined Overexpression of Bcl-2 and SOCS3 Is Associated with Decreased Survival in a Cohort of Patients with De Novo Follicular Lymphoma." Blood Vol. 106 Iss. 11 (2005) p. 989 - 989
Available at: http://works.bepress.com/carlo-bifulco/138/